LRI Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

LRI Investments’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$515	Buy	+9	New	+$493	﹤0.01%	1535
2025 Q1	–	Sell	-488	Closed	-$32K	–	1215
2024 Q4	$32K	Buy	488 +437	+857%	+$29.3K	﹤0.01%	592
2024 Q3	$3.33K	Buy	51 +9	+21%	+$752	﹤0.01%	1001
2024 Q2	$3.48K	Buy	+42	New	+$3.5K	﹤0.01%	982

Other funds holding BMRN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

LRI Investments's BMRN Position: Q2 2026 in Review

LRI Investments opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 9 shares worth $515. The stake represents ﹤0.01% of the portfolio and ranks #1535 among its holdings. This is a return to the name: LRI Investments previously reported a position in BMRN as recently as Q4 2024.

LRI Investments first reported a position in BMRN in Q2 2024 and has held it in 4 quarters since. The position peaked at $32K in Q4 2024. 97 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

LRI Investments held 9 shares of BioMarin Pharmaceuticals worth $515 as of Q2 2026.
BioMarin Pharmaceuticals was a new LRI Investments position in Q2 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1535 holding.
LRI Investments first reported a position in BioMarin Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
LRI Investments's BioMarin Pharmaceuticals position peaked at $32K in Q4 2024.
97 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.